Immediate Impact
48 standout
Citing Papers
Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Works of Thomas Gwise being referenced
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
2022
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Thomas Gwise | 92 | 52 | 52 | 93 | 70 | 23 | 290 | |
| Shanda Finnigan | 33 | 66 | 24 | 93 | 57 | 18 | 284 | |
| Monia Ezzalfani | 96 | 31 | 57 | 81 | 17 | 21 | 222 | |
| A Stone | 67 | 37 | 52 | 127 | 16 | 21 | 308 | |
| Grace Hsu | 64 | 63 | 60 | 74 | 8 | 13 | 256 | |
| Tamy Kim | 76 | 171 | 58 | 82 | 9 | 13 | 294 | |
| Z. Tomasevic | 12 | 47 | 39 | 149 | 17 | 24 | 293 | |
| Nathalie Varoqueaux | 14 | 24 | 18 | 138 | 23 | 19 | 275 | |
| Erin Zagadailov | 8 | 30 | 21 | 96 | 82 | 31 | 313 | |
| Susan Jin | 18 | 39 | 36 | 71 | 9 | 11 | 252 | |
| Robert W. Corty | 26 | 17 | 22 | 48 | 13 | 17 | 245 |
All Works
Loading papers...